Time course of gene expression after plasmid DNA gene transfer to the liver

Citation
H. Herweijer et al., Time course of gene expression after plasmid DNA gene transfer to the liver, J GENE MED, 3(3), 2001, pp. 280-291
Citations number
56
Categorie Soggetti
Molecular Biology & Genetics
Journal title
JOURNAL OF GENE MEDICINE
ISSN journal
1099498X → ACNP
Volume
3
Issue
3
Year of publication
2001
Pages
280 - 291
Database
ISI
SICI code
1099-498X(200105/06)3:3<280:TCOGEA>2.0.ZU;2-A
Abstract
Background High levels of expression in hepatocytes can be achieved after i ntraportal delivery of plasmid DNA vectors with up to 10% of all liver cell s transfected. CMV promoter-driven expression is very high on Day 1 after i njection, but is diminished strongly by Day 2. Expression slowly declines a fter 1 week. We describe experiments aimed at elucidating the reasons for t his rapid decline in transgene expression. Methods Histological methods were used to determine the presence and extent of Liver damage and hepatocyte proliferation. Viral and liver-specific pro moters were tested to study promoter shut-off, Southern blotting was perfor med to determine the loss of the pDNA vector over time, and several mouse m odels were used to study the host immunological response. Results pDNA is lost rapidly early after injection, but remains at a relati vely stable copy number after Day 4. Southern blotting experiments showed t hat plasmid DNA could be detected for at least 12 weeks after injection (0. 2 copies per genome). The early rapid decline of expression is promoter dep endent. A liver-specific albumin promoter resulted in similar levels of exp ression on Days 1 and 7, suggesting that promoter inactivation may be respo nsible for the instability of CMV promoter-driven expression. The slow decl ine in expression levels after 1 week appears to be the result of an immune response directed against the expressed transgene. Expression was much pro longed in immunosuppressed, immunodeficient, or antigen-tolerized mice. Conclusion The present data suggest that if promoter inactivation can be ov ercame, intravascular delivery of plasmid DNA could be a highly efficient, simple and non-toxic liver gene therapy approach. Intravascular delivery of pDNA allows for the rapid screening of novel expression vectors in vivo. C opyright (C) 2001 John Wiley & Sons, Ltd.